Priority Date: 20.08.10 (US 20100375464P)

SUV420H1 AND SUV420H2 AS TARGET GENES FOR CANCER THERAPY AND DIAGNOSIS

  • Application ID: EP11817936
  • Status: APPLICATION WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This EP application has the IPC combination A61, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 76 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 20.08.2010 - Priority Date (US 20100375464P)
  • 23.02.2012 - Publication A1 (WO2012023287)
  • 26.06.2013 - Publication A1 (EP2606133)